M.J. Whitehouse

Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2

Michael Simons, Brian H. Annex, Roger J. Laham et al. · Circulation · 2002 · 650 citations

Medicine, Cardiology, Pharmacotherapy +17

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

Robert J. Lederman, Farrell O. Mendelsohn, R. David Anderson et al. · The Lancet · 2002 · 515 citations

Medicine, Pharmacotherapy, Regenerative Medicine +7

Rational Design of a Combination Medication for the Treatment of Obesity

Frank L. Greenway, M.J. Whitehouse, Maria Guttadauria et al. · Obesity · 2008 · 345 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a Phase I open-label dose escalation study

Roger J. Laham, Nicholas Chronos, Marilyn C. Pike et al. · Journal of the American College of Cardiology · 2000 · 223 citations

Medicine, Cardiology, Clinical Sciences +13

Significance of intracranial pressure waveform analysis after head injury

Marek Czosnyka, E. Guazzo, M.J. Whitehouse et al. · Acta Neurochirurgica · 1996 · 185 citations

Medicine, Neurological Surgery, Neurosurgery +13